Preferred Label : E1-INT;
MeSH note : an injectable islet neogenesis therapy comprising an epidermal growth factor analog
and a gastrin analog, for the treatment of insulin-dependent (type 1) and non-insulin-dependent
(type 2) diabetes; Hypoglycemic Agents;
Is substance : O;
Origin ID : C506657;
UMLS CUI : C1680607;
MeSH term(s) associated for indexing
Record concept(s)
Semantic type(s)